However, ~60% of respondents still show a positive attitude towards future trial number growth, with confidence that China clinical development is pivoting to a high-quality growth
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · page 12 of 58
The slide combines quantitative survey data (N=101) with qualitative expert quotes to contextualize the market sentiment.
Consulting deck · testimonial · summarize · overcrowded density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 disclaimer 1/1 quote 1/1 title 2/2
Components 5
bar-stacked disclaimer testimonial action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 1
Frameworks 1